Skip to main content
SpringerLink
Log in

Genetic Risk Factors for Neural Tube Defects: Folic Acid Supplementation and Prevention of Birth Defects

  • Chapter
Pediatric Neurogenic Bladder Dysfunction

  • 1113 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al (1999). Prevention of neural tube defects with folic acid in China: China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485–90

    Article  PubMed  CAS  Google Scholar 

  2. Botto LD, Yang Q (2000). 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862–77

    PubMed  CAS  Google Scholar 

  3. Botto LD, Olney RS, Erickson JD (2004). Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet 125C: 12–21

    Article  PubMed  Google Scholar 

  4. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J (2005). International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working? Br Med J 12:571.

    Article  Google Scholar 

  5. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O’Leary VB, Parle-McDermott A, Scott JM, Swanson DA (2002). A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 71:1207–15.

    Article  PubMed  CAS  Google Scholar 

  6. Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra Mda G, Nazer-Herrera J (2003). Latin American Collaborative Study of Congenital Malformations (ECLAMC). Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet 1:123–8

    Article  Google Scholar 

  7. Central Technical Co-ordinating Unit, ICMRCentral Technical Co-ordinating Unit, ICMR (2000). Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 112:206–11.

    Google Scholar 

  8. Coelho CN, Weber JA, Klein NW, Daniels WG, Hoagland TA (1989). Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 119:1716–25.

    PubMed  CAS  Google Scholar 

  9. Czeizel AE, Dudas I (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832–1835

    Article  PubMed  CAS  Google Scholar 

  10. Czeizel AE (1998). Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78:151–61

    Article  PubMed  CAS  Google Scholar 

  11. de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP (1997). Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr 51:643–60

    Article  PubMed  CAS  Google Scholar 

  12. de Franchis R, Botto LD, Sebastio G, Ricci R, Iolascon A, Capra V, Andria G, Mastroiacovo P (2002). Spina bifida and folate-related genes: a study of gene-gene interactions. Genet Med 4:126–30.

    Article  PubMed  Google Scholar 

  13. De Marco P, Calevo MG, Moroni A, Merello E, Raso A, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V (2003). Reduced folate carrier polymorphism (80A->G) and neural tube defects. Eur J Hum Genet 11:245–52.

    Article  PubMed  CAS  Google Scholar 

  14. Dias MS, Partington M (2004). Embryology of myelomeningocele and anencephaly. Neurosurg Focus 16:1–16

    Google Scholar 

  15. Epeldegui M, Pena-Melian A, Varela-Moreiras G, Perez-Miguelsanz J (2002). Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos. Teratology 65:171–9.

    Article  PubMed  CAS  Google Scholar 

  16. Greene ND, Copp AJ (1997). Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 3:60–6

    Article  PubMed  CAS  Google Scholar 

  17. Greene ND, Dunlevy LE, Copp AJ (2003). Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat Embryol (Berl) 206:185–91

    CAS  Google Scholar 

  18. Greene ND, Copp AJ (2005). Mouse models of neural tube defects: investigating preventive mechanisms. Am J Med Genet C 15:31–41.

    Article  Google Scholar 

  19. Groenen PM, Peer PG, Wevers RA, Swinkels DW, Franke B, Mariman EC, Steegers-Theunissen RP (2003). Maternal myoinositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 189:1713–9.

    Article  PubMed  CAS  Google Scholar 

  20. Groenen PM, van Rooij IA, Peer PG, Gooskens RH, Zielhuis GA, Steegers-Theunissen RP (2004). Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol 191:11–7.

    Article  PubMed  CAS  Google Scholar 

  21. Hansen DK, Grafton TF, Melnyk S, James SJ (2001). Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod Toxicol 15:239–44.

    Article  PubMed  CAS  Google Scholar 

  22. Hibbard ED, Smithells RW (1965). Folic acid metabolism and human embryopathy. Lancet 1: 1254.

    Article  Google Scholar 

  23. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH (1999). The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340:1449–54

    Article  PubMed  CAS  Google Scholar 

  24. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM (1993). Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703–8.

    PubMed  CAS  Google Scholar 

  25. Laurence KM, James N, Miller MH, Tennant GB, Campbell H (1981). Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neuraltube defects. Br Med J (Clin Res Ed) 9:1509–11.

    Article  Google Scholar 

  26. Lewis CJ, Crane NT, Wilson DB, Yetley EA (1999). Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 70:198–207.

    PubMed  CAS  Google Scholar 

  27. Mathews TJ, Honein MA, Erickson JD (2002). Spina bifida and anencephaly prevalence: United States, 1991–2001. MMWR Recomm Rep 13:9–11.

    Google Scholar 

  28. Medical Research Council Vitamin Study Research Group (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–7

    Article  Google Scholar 

  29. Mersereau P, Kilker K, Carter H, Fassett E, Williams J, Flores A, Prue C, Williams L, Mai C, Mulinare J. Spina bifida and anencephaly before and after folic acid mandate, United States, 1995–1996 and 1999–2000. MMWR 53: 362–5

    Google Scholar 

  30. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM (1995). Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149–151

    Article  PubMed  CAS  Google Scholar 

  31. Muller F, O’Rahilly R (1987). The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12. Anat Embryol (Berl) 176:413–30.

    Article  CAS  Google Scholar 

  32. Nieuwkoop PD (1999). The neural induction process; its morphogenetic aspects. Int J Dev Biol 43:615–23

    PubMed  CAS  Google Scholar 

  33. Persad VL, Van den Hof MC, Dube JM, Zimmer P (2002). Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 6:241–5.

    Google Scholar 

  34. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, Richardson J, Lacey SW, Anderson RG, Finnell RH (1999). Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23:228–32.

    Article  PubMed  CAS  Google Scholar 

  35. Quinlivan EP, Gregory JF 3rd (2003). Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 77:221–5.

    PubMed  CAS  Google Scholar 

  36. Rader JI, Weaver CM, Angyal G (2000). Total folate in enriched cereal-grain products in the United States following fortification. Food Chem 70:275–89

    Article  CAS  Google Scholar 

  37. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J (2004). Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256–60.

    Article  PubMed  CAS  Google Scholar 

  38. Rosenquist TH, Ratashak SA, Selhub J (1996). Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227–32.

    Article  PubMed  CAS  Google Scholar 

  39. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA (1995). Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219–26.

    PubMed  CAS  Google Scholar 

  40. Shaw GM, Carmichael SL, Yang W, Schaffer DM (2005). Periconceptional dietary intake of myo-inositol and neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol 73:184–7.

    Article  PubMed  CAS  Google Scholar 

  41. Smithells RW, Sheppard S, Schorah CJ (1976). Vitamin deficiencies and neural tube defects. Arch Dis Child 51:944–50.

    Article  PubMed  CAS  Google Scholar 

  42. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J (1983). Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 7:1027–31.

    Article  Google Scholar 

  43. Spiegelstein O, Cabrera RM, Bozinov D, Wlodarczyk B, Finnell RH (2004). Folate-regulated changes in gene expression in the anterior neural tube of folate binding protein-1 (Folbp1)-deficient murine embryos. Neurochem Res 29:1105–12.

    Article  PubMed  CAS  Google Scholar 

  44. Steegers-Theunissen RPM, Boers GHJ, Trijbels JMF, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wouters MG, Eskes TK (1994). Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43:1475–80

    Article  PubMed  CAS  Google Scholar 

  45. Vanaerts LA, Blom HJ, Deabreu RA, Trijbels FJ, Eskes TK, Copius Peereboom-Stegeman JH, Noordhoek J (1994). Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology 50:348–60.

    Article  PubMed  CAS  Google Scholar 

  46. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, Blom HJ (1996). Decreased methylene tetrahydrofolate reductase activity due to the 677C->T mutation in families with spina bifida offspring. J Mol Med 74:691–4.

    Article  PubMed  Google Scholar 

  47. van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, De Graaf-Hess A, Smeitink JA, Blom HJ (1997). Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90:505–10.

    Article  PubMed  Google Scholar 

  48. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–51.

    Article  PubMed  Google Scholar 

  49. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ (1990). Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 10:149–52.

    PubMed  CAS  Google Scholar 

  50. Werler MM, Shapiro S, Mitchell AA (1993). Periconceptional folic acid exposure and risk of occurrent neural tube defects. J Am Med Assoc 10:1257–61.

    Article  Google Scholar 

  51. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, Stoll C, Alembik Y, Dott B, Czeizel AE, Gelman-Kohan Z, Scarano G, Bianca S, Ettore G, Tenconi R, Bellato S, Scala I, Mutchinick OM, Lopez MA, de Walle H, Hofstra R, Joutchenko L, Kavteladze L, Bermejo E, Martinez-Frias ML, Gallagher M, Erickson JD, Vollset SE, Mastroiacovo P, Andria G, Botto LD (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40:619–25.

    Article  PubMed  CAS  Google Scholar 

  52. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317–23

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, “Federico II” University of Naples, Via Pansini 5, 80131, Naples, Italy

    Generoso Andria & Iris Scala

Authors
  1. Generoso Andria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iris Scala
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. “Magna Graecia” University of Catanzaro, Via Tommaso Campanella 115, 88100, Catanzaro, Italy

    Ciro Esposito (Chair of Pediatric Surgery) (Chair of Pediatric Surgery)

  2. Pediatric Surgery, La Timone Childrens Hospital, Bd. Jean Moulin 1, 13005, Marseille, France

    Jean Michel Guys

  3. Children’s Hospital of Manchester, Manchester, M13 9PL, UK

    David Gough

  4. “Federico II” University of Naples, Via Pansini 5, 80131, Naples, Italy

    Antonio Savanelli (Chair of Pediatric Surgery) (Chair of Pediatric Surgery)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Andria, G., Scala, I. (2006). Genetic Risk Factors for Neural Tube Defects: Folic Acid Supplementation and Prevention of Birth Defects. In: Esposito, C., Guys, J.M., Gough, D., Savanelli, A. (eds) Pediatric Neurogenic Bladder Dysfunction. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30867-9_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-30867-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30866-9

  • Online ISBN: 978-3-540-30867-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation